Neonatal sepsis
Neonatal sepsis refers to the invasion of neonatal blood circulation by pathogenic bacteria through various pathways during the neonatal period, in which they grow and multiply, produce toxins and cause systemic infection. The incidence and mortality of the disease are high in the neonatal period. With the deepening of the study of systemic inflammatory response syndrome, the definition of sepsis is also constantly expanding, including systemic inflammation and infection caused by endogenous infectious factors (such as intestinal flora) after activation. Neonatal sepsis generally refers to a pathological process in which bacteria exist and continue to multiply in the blood, and positive bacterial results can be obtained through blood culture. The diagnosis can also be made when there is evidence of bacterial-immunological diagnosis but no positive blood culture results are obtained. It is still a very important disease in the neonatal period, with an incidence of about 1‰ to 10‰ of live births, and the incidence is higher in premature infants.
-
Site of disease:
whole body -
Infectious :
Not contagious -
Frequent population:
Newborns -
Related symptoms:
Irritability abdominal distension ecchymosis hepatosplenomegaly mental depression -
Concurrent disease:
Related Drugs
Intravenous human immunoglobulin (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Manufacturer:
Hualan Biological Engineering,Inc.
Lyophilized human immunoglobulin for intravenous injection (pH4)
Indication: 1. Primary immunoglobulin deficiency such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Human immunoglobulin
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura and Kawasaki disease.
Manufacturer:
Shenzhen Weiguang Biological Products Co., Ltd.
Intravenous human immunoglobulin (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Manufacturer:
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
Intravenous human immunoglobulin (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Manufacturer:
Green Blood Products (Liaoning) Co., Ltd.
Intravenous human immunoglobulin (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Manufacturer:
Sinopharm Shanghai Plasma-derived Biotherapies Co., Ltd.
Lyophilized human immunoglobulin for intravenous injection (pH4)
Indication: 1. Primary immunoglobulin deficiency such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Lyophilized human immunoglobulin for intravenous injection (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura and Kawasaki disease.
Manufacturer:
Shenzhen Weiguang Biological Products Co., Ltd.
Lyophilized human immunoglobulin for intravenous injection (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura and Kawasaki disease.
Manufacturer:
Shenzhen Weiguang Biological Products Co., Ltd.
Lyophilized human immunoglobulin for intravenous injection (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura and Kawasaki disease.